Energenesis Biomedical CO.,LTD. (TPE:6657)

TPE:6657 Revenue

Energenesis Biomedical CO.,LTD. had revenue of 1.39M TWD in the quarter ending March 31, 2026, with 14.67% growth. This brings the company's revenue in the last twelve months to 7.85M, up 3.94% year-over-year. In the year 2025, Energenesis Biomedical CO.,LTD. had annual revenue of 7.67M, down -0.97%.

• Revenue (ttm): 7.85M
• Revenue Growth: +3.94%
• P/S Ratio: 432.50
• Revenue / Employee: n/a
• Employees: 35
• Market Cap: 3.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.67M	-75.00K	-0.97%
Dec 31, 2024	7.75M	591.00K	8.26%
Dec 31, 2023	7.16M	-193.00K	-2.63%
Dec 31, 2022	7.35M	-138.00K	-1.84%
Dec 31, 2021	7.49M	408.00K	5.76%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error